Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

48.55
-0.9700-1.96%
Post-market: 49.520.9700+2.00%19:59 EDT
Volume:760.57K
Turnover:36.92M
Market Cap:3.85B
PE:6.46
High:49.42
Open:48.90
Low:48.05
Close:49.52
Loading ...

Leerink Partners Sticks to Their Hold Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
02 Jul

BRIEF-Sephience™ (Sepiapterin) Granted Marketing Authorization By The European Commission

Reuters
·
23 Jun

PTC Therapeutics Secures European Commission Approval for Sephience™ to Treat Phenylketonuria in All Ages and Severities

Reuters
·
23 Jun

Sephience™ (Sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living With Phenylketonuria (Pku)

THOMSON REUTERS
·
23 Jun

BRIEF-PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
20 Jun

PTC Therapeutics Announces New Employee Compensation Plan with Stock Options and RSUs

Reuters
·
20 Jun

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Jun

PTC Therapeutics Elects Directors at Annual Meeting

TIPRANKS
·
18 Jun

PTC Therapeutics Inc. Conducted Annual Meeting of Stockholders

Reuters
·
18 Jun

PTC Therapeutics Initiated at Buy by Truist Securities

Dow Jones
·
17 Jun

PTC Therapeutics Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $80

THOMSON REUTERS
·
17 Jun

PTC Therapeutics initiated with a Buy at Truist

TIPRANKS
·
17 Jun

PTC Therapeutics: Strong Buy Rating Backed by Promising Sepiapterin Launch and Robust Financial Outlook

TIPRANKS
·
05 Jun

RBC Raises Price Target on PTC Therapeutics to $60 From $58, Keeps Outperform Rating

MT Newswires Live
·
04 Jun

PTC Therapeutics: Promising Pipeline and Strategic Preparations Justify Buy Rating

TIPRANKS
·
04 Jun

PTC Therapeutics Unveils 2025 Corporate Presentation Highlighting Regulatory Approvals and Revenue Growth

Reuters
·
03 Jun

Citi Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
03 Jun

RBC Capital views FDA flexibility on another HD drug as positive for PTC’s ‘518

TIPRANKS
·
02 Jun

PTC Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
27 May

Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), PTC Therapeutics (PTCT)

TIPRANKS
·
27 May